Loading…
InspireMD, Inc.
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Major managers that reported this stock in their latest 13F.
▼ -82.3% over 5Y.
today you would have $170.73▼ -82.9%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
The last 15 closed years. Each multiple uses that year’s closing price and that year’s reported numbers — not today’s. The range is set by the annual reports on record.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Year-end price | $1.78 | $2.63 | $2.81 | $0.86 | $3.02 | $5.10 | $16.20 | $120.00 | $3,412.50 | $65,625.00 | $577,500.00 | $5,118,750.00 | $16,143,750.00 | $25,593,750.00 | $57,225,000.00 | |
| P/S | 11.1x | 9.3x |
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| ACTUActuate Therapeutics Inc | $1.66 | — | 40.4x | — | — | $39.74M |
| KPTIKaryopharm Therapeutics Inc. | $1.75 | — | — | — | — | $39.69M |
| SNWVSANUWAVE Health, Inc. | $4.68 | 5.8x | 21.8x | — | — | $40.22M |
| PAVMPAVmed Inc. | $4.92 |
InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery disease and other vascular conditions in the United States, Germany, Italy, Russia, Poland, and internationally. It offers MicroNet, a biocompatible polymer mesh material for medical implants, as well as for treating plaque prolapse and embolization; CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Carotid Stent System; and SwitchGuard neuroprotection system to provide flow reversal of cerebral protection in carotid interventions, as well as treating acute stroke with tandem lesions. The company was founded in 2005 and is headquartered in Miami, Florida.
Company description provided by Yahoo Finance.
| 11.1x |
| 10.6x |
| 1.4x |
| 5.6x |
| 16.1x |
| 1.3x |
| 1.9x |
| 2.8x |
| 68.0x |
| 143.0x |
| 757.5x |
| 609.6x |
| 435.4x |
| 867.3x |
| P/B | 2.2x | 1.5x | 2.2x | 1.7x | 0.4x | 0.7x | 3.3x | 0.9x | 0.8x | 2.8x | 31.8x | — | — | 184.5x | 432.4x | 771.0x |
| EPS | -$0.76 | -$0.76 | -$0.82 | -$2.35 | -$2.03 | -$6.97 | -$72.00 | -$250.05 | -$26,235.00 | -$155,790.00 | -$41,887.50 | -$132,937.50 | -$260,625.00 | -$195,000.00 | -$180,000.00 |
| Profit margin | -357.59% | -543.33% | -456.63% | -320.97% | -357.59% | -331.88% | -424.31% | -269.82% | -201.06% | -305.61% | -446.73% | -674.68% | -890.53% | -600.41% | -328.98% | -244.25% |
| ROE | -106.31% | -88.38% | -88.69% | -50.42% | -106.31% | -44.49% | -86.69% | -186.51% | -82.62% | -309.42% | -209.17% | — | — | -181.70% | -326.72% | -217.13% |
Median, not average: a single year of near-zero profit produces a P/E of 400 and would drag an average on its own. P/E years above 200x are left out, the same cut the fair price uses — so this median matches the “its own history” method below. Price and EPS have no median: they are series that grow.
| — |
| 1.0x |
| — |
| -64.78% |
| $39.34M |
| DCGODocGo Inc. | $0.40 | — | 0.3x | — | -107.79% | $39.32M |
| CRVOCervoMed Inc. | $2.60 | — | 1.5x | — | -107.62% | $39.31M |